BA
VNRX icon

BlackRock Advisors’s VolitionRx Ltd VNRX Stock Holding History

BlackRock Advisors’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$29K Hold
320
– – ﹤0.01% 3379
2016
Q3 		$34K Buy
320
+249
+351% +$19.3K ﹤0.01% 3340
2016
Q2 		$4K Hold
71
– – ﹤0.01% 3689
2016
Q1 		$5K Hold
71
– – ﹤0.01% 3668
2015
Q4 		$6K Buy
+71
New +$6.02K ﹤0.01% 3698

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

BlackRock Advisors's VNRX Position: Q4 2016 in Review

BlackRock Advisors held its VolitionRx Ltd (VNRX) position steady in Q4 2016 at 320 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #3379.

BlackRock Advisors first reported a position in VNRX in Q4 2015 and has held it in 5 quarters since. The position peaked at $34K in Q3 2016. 17 funds tracked by Wall St. Rank hold VNRX as of Q4 2016.

  • BlackRock Advisors held 320 shares of VolitionRx Ltd worth $29K as of Q4 2016.
  • BlackRock Advisors left its VolitionRx Ltd share count unchanged in Q4 2016.
  • VolitionRx Ltd made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3379 holding.
  • BlackRock Advisors first reported a position in VolitionRx Ltd in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Advisors's VolitionRx Ltd position peaked at $34K in Q3 2016.
  • 17 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.